Trial Profile
Multiple-ascending dose trial of CM3.1-AC100 in patients with type 2 diabetes mellitus
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 08 Feb 2010
Price :
$35
*
At a glance
- Drugs Glucagon-like peptide-1 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 04 Dec 2009 New trial record